SEC Form 4 · accession 0001093557-18-000163
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Augustinos
Director
Period of report
Aug 6, 2018
Accepted (ET)
Aug 8, 2018 · 8:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 6, 2018 | S | 6,100 | $120.9129 | D | 10,772 | D | |
| Common StockF3,F2 | Aug 6, 2018 | S | 2,970 | $121.721 | D | 7,802 | D | |
| Common StockF4 | Aug 6, 2018 | S | 3,230 | $121.765 | D | 14,362 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $120.37 to $121.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F2Included in this number are 3,449 restricted stock units which were granted on June 1, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.
- F3This transaction was executed in multiple trades at prices ranging from $121.39 to $122.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.